Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Top Cited Papers
- 1 October 2007
- journal article
- other
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 176 (7) , 636-643
- https://doi.org/10.1164/rccm.200703-463pp
Abstract
The natural history of idiopathic pulmonary fibrosis (IPF) has been characterized as a steady, predictable decline in lung function over time. Recent evidence suggests that some patients may experience a more precipitous course, with periods of relative stability followed by acute deteriorations in respiratory status. Many of these acute deteriorations are of unknown etiology and have been termed acute exacerbations of IPF. This perspective is the result of an international effort to summarize the current state of knowledge regarding acute exacerbations of IPF. Acute exacerbations of IPF are defined as acute, clinically significant deteriorations of unidentifiable cause in patients with underlying IPF. Proposed diagnostic criteria include subjective worsening over 30 days or less, new bilateral radiographic opacities, and the absence of infection or another identifiable etiology. The potential pathobiological roles of infection, disordered cell biology, coagulation, and genetics are discussed, and future research directions are proposed.Keywords
This publication has 81 references indexed in Scilit:
- Adult-onset pulmonary fibrosis caused by mutations in telomeraseProceedings of the National Academy of Sciences, 2007
- Telomerase Mutations in Families with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2007
- Circulating peripheral blood fibrocytes in human fibrotic interstitial lung diseaseBiochemical and Biophysical Research Communications, 2006
- Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumoniaThorax, 2006
- Classification and Natural History of the Idiopathic Interstitial PneumoniasProceedings of the American Thoracic Society, 2006
- The Genetic Approach in Pulmonary Fibrosis: Can It Provide Clues to This Complex Disease?Proceedings of the American Thoracic Society, 2006
- Idiopathic Pulmonary FibrosisDrugs, 2004
- Terminal Diffuse Alveolar Damage in Relation to Interstitial PneumoniasAmerican Journal of Clinical Pathology, 2003
- Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.Thorax, 1995
- Natural History and Treated Course of Usual and Desquamative Interstitial PneumoniaNew England Journal of Medicine, 1978